Search
Filter Results
Displaying 41–50 of 1178 results
-
- Sep 19, 2026
- 9:00 a.m. - 12:00 p.m. (PDT)
- 2000 Ocean Ave, Santa Monica, CA 90405
VisionWalkJoin us for the 20th Annual Los Angeles VisionWalk!
-
- Sep 17, 2026
- 6:00 p.m. - 8:00 p.m. (EDT)
- 4600 N Tryon St, Charlotte, NC 28213
Community EventConnect, Explore, and Empower: Charlotte Vision Connection
-
Triangle-Triad Virtual Lunch and Learn (September)
- Sep 17, 2026
- 12:00 p.m. (EDT)
- Virtual
Community EventAccessible Voting in North Carolina
-
Sep 16, 2026
What You Cannot See Through a Mothers Eyes
Invisible DisabilityA mothers perspective on her infant sons journey with bilateral congenital cataracts.
-
Sep 15, 2026
Retinitis Pigmentosa Research Advances
Research NewsRecent developments in research for retinitis pigmentosa treatments.
-
Sep 14, 2026
Finding the Light Within: How Joslyn Turned Vision Loss into Purpose
Beacon StoriesJoslyn Marquez spent years searching for answers before being diagnosed with retinitis pigmentosa at the age of 16. Rather than allowing vision loss to define her, she transformed her journey into a source of purpose, community and empowerment.
-
Sep 10, 2026
Foundation NewsThe new name honors the decades of leadership and giving by Foundation co-founder Gordon Gund and his family, honoring the Fund’s evolution into one of the most innovative venture philanthropy models in the retinal disease market.
-
The following list of doctors has been compiled by the Foundation Fighting Blindness for the convenience of patients and families. The accuracy of the list cannot be guaranteed nor should it be construed as an endorsement of any doctor.
-
Sep 2, 2026
Eye on the Cure Podcast | Episode 103: Kenyetta McCurdy-Byrd and Heather Edwards
Eye on the CureTwo non-profit professionals talk about plugging into community and finding low-vision resources through the Foundation.
-
Aug 27, 2026
First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America
Research NewsCell therapy DSP-3077 is in Phase 1/2a clinical trials